Advertise With UsAdvertise on our extensive network of industry websites and newsletters.
Get the PBR newsletterSign up to our free email to get all the latest PBR
news.Simulations Plus has signed a multi-year collaboration agreement with Hoffmann La Roche that will provide funding for the equivalent of one full-time scientist for two years to expand the capabilities of its flagship GastroPlus software program.
Subscribe to our email newsletter
The agreement includes close collaboration with Roche scientists to advance the capabilities of GastroPlus in the area of simulating drug-drug interactions.
Walt Woltosz, chairman and CEO of Simulations Plus, said: “This collaboration will provide funding and data to enable us to move GastroPlus to the forefront in the prediction of drug-drug interactions. Simulations Plus will also contribute to this effort from our in-house R&D funds. Drug-drug interactions are one of the most critical aspects of bringing new drugs to market.”